drug · unknown
galinpepimut-S
Phase 3updated 5mo agoby $SLS SELLAS Life Sciences Group, Inc.🔗 ChEMBL
Phase 3community read0 votes
Unknown drug with a maximum clinical stage of Phase 3 (across all indications), with 6 investigational indications.
targets
Wilms tumor protein
all catalysts(0)
nothing on the calendar yet
Trials studying galinpepimut-S
- —Expanded Access Program (EAP) for Galinpepimut-S (GPS) in Patients Diagnosed With AML or MDS
- phase3Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2
- phase2WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)
- phase2Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers
- phase2Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy
- phase2WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell Transplantation
News(1)
- STAT+: A Sellas immunotherapy study, long delayed, will end in failureWhy Sellas' experimental immunotherapy study is a blowup waiting to happen.stat · 12d ago
Data sources
last refreshed 6h ago
Found something off?
comments(0)
5-min edit window · permanent after that